Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 336

    USFDA nod for Zydus Pharmaceuticals OCD treatment drug

    USFDA nod for Zydus Pharmaceuticals OCD treatment drug

    Ruby Khatun Khatun30 Dec 2017 11:00 AM IST
    New Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clomipramine Hydrochloride capsules,...
    Brazil gives nod for Mylan-Biocons breast cancer biosimilar trastuzumab 

    Brazil gives nod for Mylan-Biocon's breast cancer biosimilar trastuzumab 

    Ruby Khatun Khatun30 Dec 2017 10:30 AM IST
    New Delhi: Drug major Biocon and Mylan's proposed biosimilar trastuzumab has been approved by Brazilian regulatory agency ANVISA, through their...
    Marketing of device to treat diabetic foot ulcers permitted by FDA

    Marketing of device to treat diabetic foot ulcers permitted by FDA

    Ruby Khatun Khatun30 Dec 2017 10:00 AM IST
    The U.S. Food and Drug Administration (FDA) permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic...
    Gene therapy finds a place in medicine, 2017 memorable year

    Gene therapy finds a place in medicine, 2017 memorable year

    Ruby Khatun Khatun30 Dec 2017 9:30 AM IST
    After decades of hope and high promise, this was the year scientists really showed they could doctor DNA to successfully treat diseases. Gene...
    USFDA gives nod to Lupin generic psoriasis treatment solution

    USFDA gives nod to Lupin generic psoriasis treatment solution

    Ruby Khatun Khatun29 Dec 2017 11:00 AM IST
    New Delhi: Pharma major Lupin Ltd said it has received final approval from the US health regulator for its generic version of Dovonex scalp solution...
    Patanjali to enter diaper and sanitary napkin market

    Patanjali to enter diaper and sanitary napkin market

    Ruby Khatun Khatun29 Dec 2017 10:30 AM IST
    After making headway into several markets, Patanjali Ayurveda is now eyeing the diaper and sanitary napkin industry, to take on the international...
    Pharma cos revenues to grow 9 percent over next 3 yrs

    Pharma cos revenues to grow 9 percent over next 3 yrs

    Ruby Khatun Khatun29 Dec 2017 10:00 AM IST
    Mumbai: Robust domestic demand and rising need for complex products in the West will help domestic pharma players log in a 9 percent revenue growth...
    Martin Shkrelis Ex-lawyer convicted of aiding fraud scheme

    Martin Shkreli's Ex-lawyer convicted of aiding fraud scheme

    Ruby Khatun Khatun29 Dec 2017 9:30 AM IST
    A New York lawyer who once advised Martin Shkreli was convicted on Wednesday of helping him defraud a pharmaceutical company, a charge a different...
    USFDA gives nod to Glenmarks contraceptive drug

    USFDA gives nod to Glenmark's contraceptive drug

    Ruby Khatun Khatun28 Dec 2017 10:30 AM IST
    New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for a generic version of Minastrin 24 tablets used for...
    Governments price caps pinches pharma, private hospitals in 2017

    Government's price caps pinches pharma, private hospitals in 2017

    Ruby Khatun Khatun28 Dec 2017 10:00 AM IST
    New Delhi: Indian pharmaceutical and healthcare sectors will step into the new year with lingering bitter after-effects of proactive measures of the...
    PerkinElmer to expand investment portfolio in India

    PerkinElmer to expand investment portfolio in India

    Ruby Khatun Khatun28 Dec 2017 10:00 AM IST
    New Delhi: PerkinElmer, Inc., a US-based Global leader committed to innovating for a healthier world, is exploring opportunities to invest in India in...
    Valeant gets FDA nod for Lumify eye drop

    Valeant gets FDA nod for Lumify eye drop

    Ruby Khatun Khatun28 Dec 2017 9:45 AM IST
    Canadian drugmaker Valeant Pharmaceuticals International Inc said the U.S. Food and Drug Administration approved Lumify drop to treat eye redness.The...
    PrevNext

    Popular Stories

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok